3-benzoyl dopamine has been researched along with Arthritis, Rheumatoid in 5 studies
*Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 4 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelhafiz, A; Abdelhafiz, D; Baker, T; Glascow, DA | 1 |
| Alvarez, DF; Bock, AE; Iikuni, N; Kay, J; Rehman, M; Zhang, M; Zhang, W | 1 |
| Ascsillán, A; Bakó, E; Bánvölgyi, A; Csupor, D; Dembrovszky, F; Gunther, E; Hegyi, P; Kemény, LV; Lutz, E; Meznerics, FA; Nagy, G; Szabó, B | 1 |
| Fautrel, B; Hajage, D; Kossi, S; Marotte, H; Moysidou, GS; Tubach, F | 1 |
| Calabrese, LH | 1 |
2 review(s) available for 3-benzoyl dopamine and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Biomarkers for the diagnosis and treatment of rheumatoid arthritis - a systematic review.
Topics: 14-3-3 Proteins; Arthritis, Rheumatoid; Biomarkers; C-Reactive Protein; Humans; Prognosis | 2023 |
Multibiomarker disease activity score: an objective tool for monitoring rheumatoid arthritis? A systematic review and meta-analysis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Biomarkers; Disease Progression; Humans; Severity of Illness Index | 2023 |
1 trial(s) available for 3-benzoyl dopamine and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Ability to predict rheumatoid arthritis relapse after tumour necrosis factor inhibitor tapering by the Multi-Biomarker Disease Activity Score: a post-hoc analysis of the STRASS trial.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Biomarkers; Chronic Disease; Humans; Recurrence; Severity of Illness Index; Tumor Necrosis Factor Inhibitors | 2023 |
2 other study(ies) available for 3-benzoyl dopamine and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Use of multibiomarker disease activity scores in biosimilarity studies for the treatment of patients with rheumatoid arthritis.
Topics: Adalimumab; Adult; Arthritis, Rheumatoid; Biosimilar Pharmaceuticals; Dopamine; Humans; Infliximab; Randomized Controlled Trials as Topic | 2022 |
MBDA: A Valuable Tool for Medical Decision Making.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Decision-Making; Dopamine; Humans | 2019 |